Protagonist Therapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Net Income	-78.96	-127.39	-125.55	-66.15	-77.19	-38.92	-36.96	-37.74	-14.93	-11.22
Depreciation & Amortization	3.31	3.37	2.78	2.72	2.52	0.53	0.41	0.32	0.25	0.26
Share-Based Compensation	29.29	24.2	16.4	7.9	8.35	6.92	4.24	2.13	0.1	0.04
Other Operating Activities	-23.89	-8.32	-1.48	-16.96	24.78	-18.47	36.18	5.32	0.2	3.18
Operating Cash Flow	-70.24	-108.14	-107.87	-72.48	-41.53	-49.95	3.87	-29.97	-14.39	-7.74
Capital Expenditures	-0.61	-0.8	-1.1	-0.47	-0.97	-0.49	-0.67	-0.35	-0.4	-0.3
Change in Investments	-38.65	92.26	-14.76	-90.49	-52.74	2.7	16.49	-58.98	-7.87	0
Investing Cash Flow	-39.26	91.47	-15.86	-90.97	-53.71	2.21	15.82	-59.33	-8.26	-0.3
Share Issuance / Repurchase	132.66	14.55	123.83	255.37	34.49	23.18	64.55	83.65	0	0
Debt Issued / Paid	0	0	0	-10.52	9.77	0	0	0	0	0
Other Financing Activities	37.82	4.29	6.09	2.79	1.78	0.93	1.01	22.66	17.42	9
Financing Cash Flow	170.48	18.84	129.92	247.63	46.04	24.12	65.55	106.31	17.42	9
Exchange Rate Effect	0	-0.09	-0.13	0.18	-0.03	-0.18	0.15	0.02	-0.04	-0.1
Net Cash Flow	60.98	2.08	6.07	84.35	-49.23	-23.8	85.4	17.03	-5.27	0.86
Free Cash Flow	-70.85	-108.93	-108.97	-72.96	-42.49	-50.43	3.21	-30.32	-14.78	-8.04
Free Cash Flow Margin	-118.08%	-409.81%	-398.31%	-254.84%	-18395.67%	-163.08%	15.98%	-	-	-
Free Cash Flow Per Share	-1.25	-2.22	-2.35	-2.12	-1.64	-2.25	0.18	-4.66	-58.73	-35.40

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).